Zobrazeno 1 - 10
of 113
pro vyhledávání: '"Jamie Findlow"'
Publikováno v:
Infectious Diseases and Therapy, Vol 13, Iss 12, Pp 2489-2507 (2024)
Abstract Invasive meningococcal disease (IMD) is associated with high morbidity and mortality and predominantly caused by five Neisseria meningitidis serogroups (A/B/C/W/Y). Polysaccharide conjugate vaccines induce T-cell-dependent immune responses,
Externí odkaz:
https://doaj.org/article/262baf2e32ee45b893b05181b687ed8d
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 614-635 (2024)
Introduction Invasive meningococcal disease (IMD) is potentially fatal and associated with severe sequelae among survivors. It is preventable by several vaccines, including meningococcal vaccines targeting the most common disease-causing serogroups (
Externí odkaz:
https://doaj.org/article/5b2d2b937d1a4d48b8634fde57c41844
Autor:
Ray Borrow, Jamie Findlow
Publikováno v:
Expert Review of Vaccines, Vol 23, Iss 1, Pp 445-462 (2024)
ABSTRACTIntroduction The epidemiology of invasive meningococcal disease (IMD), a rare but potentially fatal illness, is typically described as unpredictable and subject to sporadic outbreaks.Areas covered Meningococcal epidemiology and vaccine use du
Externí odkaz:
https://doaj.org/article/c4930f5a866149acb22e48088f324df9
Autor:
David E. Bloom, Paolo Bonanni, Federico Martinón-Torres, Peter C. Richmond, Marco A. P. Safadi, David M. Salisbury, Apostolos Charos, Katharina Schley, Jamie Findlow, Paul Balmer
Publikováno v:
Infectious Diseases and Therapy, Vol 12, Iss 12, Pp 2649-2663 (2023)
Abstract The global invasive meningococcal disease (IMD) landscape changed considerably during the COVID-19 pandemic, as evidenced by decreased incidence rates due to COVID-19 mitigation measures, such as limited social contact, physical distancing,
Externí odkaz:
https://doaj.org/article/c523a0068eb04bd1a5c9763bb74ef4ba
Publikováno v:
Expert Review of Vaccines, Vol 22, Iss 1, Pp 839-848 (2023)
Introduction Invasive meningococcal disease (IMD) is a severe, life-threatening condition caused by infection with Neisseria meningitidis. Currently available vaccines offer protection against the five most common meningococcal disease-causing serogr
Externí odkaz:
https://doaj.org/article/0028005609cf427382b799e17f619924
Autor:
Rodolfo Villena, Paula Kriz, Myint Tin Tin Htar, Cindy Burman, Jamie Findlow, Paul Balmer, Luis Jodar
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 19, Iss 2 (2023)
In response to escalating cases of serogroup W (MenW) invasive meningococcal disease (IMD), multiple countries introduced quadrivalent conjugate MenACWY vaccines into their national immunization programs (NIPs). Here, we summarize the real-world impa
Externí odkaz:
https://doaj.org/article/d2ffd0826ad547fa9d46452b36f52505
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 7, Pp 2205-2215 (2021)
Many countries are replacing meningococcal serogroup C (MenC) conjugate vaccines (MCCV) with quadrivalent conjugate (MenACWY) vaccines, such as MenACWY-TT (Nimenrix®). This review examined eight studies comparing MenC immune responses induced by Men
Externí odkaz:
https://doaj.org/article/7c00dfce82de454db382e432fa972b53
Autor:
Katharina Schley, Jack C. Kowalik, Shannon M. Sullivan, Andrew Vyse, Carole Czudek, Eszter Tichy, Jamie Findlow
Publikováno v:
Vaccines, Vol 11, Iss 5, p 940 (2023)
A combined Haemophilus influenzae type b (Hib)/meningococcal serogroup C (MenC) vaccine will soon be unavailable in the UK immunisation schedule due to discontinuation by the manufacturer. An interim statement by the Joint Committee on Vaccination an
Externí odkaz:
https://doaj.org/article/13451c71095f47b589fa4f072df47511
Autor:
Myint Tin Tin Htar, Sally Jackson, Paul Balmer, Lidia Cristina Serra, Andrew Vyse, Mary Slack, Margarita Riera-Montes, David L. Swerdlow, Jamie Findlow
Publikováno v:
BMC Public Health, Vol 20, Iss 1, Pp 1-15 (2020)
Abstract Background Monovalent meningococcal C conjugate vaccine (MCCV) was introduced into the routine immunization program in many countries in Europe and worldwide following the emergence of meningococcal serogroup C (MenC) in the late 1990s. This
Externí odkaz:
https://doaj.org/article/f10550c29f1f4c9989fe1bc2c6c4e7ff
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 15, Iss 10, Pp 2491-2500 (2019)
Invasive meningococcal disease is rare and potentially devastating but often vaccine-preventable. Evaluation of meningococcal vaccine effectiveness is impractical owing to relatively low disease incidence; protection is therefore estimated using seru
Externí odkaz:
https://doaj.org/article/e55c5a0b8bef424ca9867453665439bb